Xpand-W Dry Syrup is a combination antibiotic formulation containing Amoxycillin 200 mg and Clavulanic Acid 28.5 mg per dose, designed for oral suspension use. Amoxycillin, a broad-spectrum penicillin antibiotic, inhibits bacterial cell wall synthesis, leading to cell lysis and death, while Clavulanic Acid, a beta-lactamase inhibitor, prevents enzymatic degradation of Amoxycillin by beta-lactamase-producing bacteria, thereby extending its antimicrobial spectrum. This synergistic combination is effective against a wide range of Gram-positive and Gram-negative pathogens responsible for respiratory tract infections, otitis media, sinusitis, skin and soft tissue infections, and urinary tract infections. Xpand-W Dry Syrup is particularly useful in pediatric patients due to its palatable formulation and ease of administration. The dosage and duration of therapy should be determined based on the severity of infection, patient age, and renal function. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and vomiting, as well as hypersensitivity reactions in susceptible individuals. Caution is advised in patients with a history of penicillin allergy or hepatic impairment. Proper reconstitution and storage conditions should be followed to maintain drug stability and efficacy. Xpand-W Dry Syrup should be used under medical supervision to ensure appropriate antimicrobial stewardship and to minimize resistance development.